Table 2.
Chinese herbal injections | Clinical/biological effects | Study type | References |
---|---|---|---|
XueBiJing injection | Normalized body temperature, IL-6 ↓, improved CT imaging results, negative time for nucleic acid testing ↓ | Retrospective case-control study | [26] |
Pneumonia severity index and score ↓, oxygenation index ↑, PaCO2 ↑, lymphocyte ↑, TNF-α ↓, IP-10 ↓, MIP-1β ↓, RANTES ↓ | Single-center retrospective study | [29] | |
White blood cell ↑, lymphocyte ↑, CRP ↓, erythrocyte sedimentation rate ↓ | Randomized controlled study | [30] | |
IL-6 ↓, IL-8 ↓, TNF-α ↓, CRP ↓, lymphocyte ↑, mechanical ventilation rate ↓, septic shock rate ↓, disease deterioration ↓, ICU hospitalization stay ↓ | Prospective randomized controlled trial | [31] | |
XiYanPing injection | Time of SARS-CoV-2 RNA clearance ↓, lung lesion opacity absorbed ↑, CRP ↓, erythrocyte sedimentation rate ↓, serum ferritin ↓, myoglobin ↓ | Retrospective case series study | [41] |
ReDuNing injection | Symptom resolution rate ↑, time to clinical symptoms resolution ↓, time to nucleic acid test turning negative ↓, hospital stay ↓, time to defervescence ↓ | Randomized, open-labeled, multicenter, controlled study | [48] |
TanReQing injection | Pathological symptoms ↓, disease deterioration ↓, effective rate ↑ | Single-center retrospective study | [54] |
ShenMai injection | SARS-CoV-2 RNA clearance time ↓, CRP level ↓, erythrocyte sedimentation rate ↓, serum ferritin ↓, myoglobin ↓, improvement rate of chest CT manifestations ↑ | Retrospective case series study | [41] |
CRP, C-reactive protein; CT, computerized tomography; ICU, intensive care unit; IL, interleukin; IP-10, interferon-inducible protein-10; MIP-1β, macrophage inflammatory protein 1β; PaCO2, partial pressure of carbon dioxide in arterial blood; RANTES, regulated on activation normal T-cell expressed and secreted chemokine; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; TNF, tumor necrosis factor.